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Estrogens exert a powerful inﬂuence during
development that can permanently affect
neuroendocrine function as well as the devel-
opment and endocrine control of reproduc-
tive tract tissues and the mammary glands.
The revelation that some environmental
chemicals can mimic the effects of estrogens
raises concerns for human health, particu-
larly when exposure occurs at stages of tissue
organization and development such as dur-
ing gestation or during the neonatal period
of life (1). One such chemical is bisphenol A
(BPA), a monomer used in the manufacture
of polycarbonate plastics and resins. Low
levels of BPA may be ingested routinely by
humans as the compound leaches from the
lining of tin cans into foods (2), from dental
sealants into saliva (3), and from polycar-
bonate bottles into their contents (4). BPA
is approximately 10,000-fold less potent
than 17β-estradiol when tested for prolifera-
tive activity and indigenous gene expression
in estrogen-responsive cultured cell lines
(3,5), in reporter gene assays (6,7), and in
receptor binding assays (8). Because of its
low potency relative to estradiol, current
environmental exposure levels to BPA have
been considered orders of magnitude below
the dose required for adverse effects on
health (9).
Studies in rodent models have yielded
conflicting results regarding the effects of
exposure to BPA that are influenced by the
species and by the speciﬁc strains examined as
well as by the dose, the route of administra-
tion, and the time of exposure (10–16). For
example, Fischer 344 rats appear to be particu-
larly sensitive to BPA. Ovariectomized animals
exhibited approximately a 2-fold increase in
uterine wet weight following 3 days of expo-
sure to 0.3 mg BPA/kg body weight (bw)
delivered by a subcutaneous implant (10). In
contrast, identical treatment had no effect on
uterine wet weight in Sprague-Dawley females
(10). Prepubertal Long Evans rats showed a
signiﬁcant increase in uterine wet weight in
response to 200 mg BPA/kg bw/day for 3
days; however, administration of 100 mg
BPA/kg bw in the same regimen was ineffec-
tive (16). Immature Alpk:AP rats exhibited a
uterotropic response to 400 mg BPA/kg bw as
evidenced by a 1.3-fold and a 1.5-fold increase
in wet weight after oral gavage and subcuta-
neous injection, respectively (17). Although
some evidence suggests that mice may be less
likely than rats to exhibit a uterotropic
response to BPA (6), results of a recent study
revealed that the continuous subcutaneous
administration of 100 mg BPA/kg bw/day for
3 days did elicit a uterotropic response in CD1
mice (18). Other end points that have been
studied after BPA administration to adult ani-
mals—such as induction of cell proliferation
in the uterus and the vagina, and prolactin
secretion—also revealed differences in sensitiv-
ity among rat strains (10,11). Again, Sprague-
Dawley rats proved less sensitive to BPA than
Fisher 344 rats in these studies.
The route and time of exposure can also
affect the potency of BPA. Results of a recent
study indicated that the relative bioavailability
of BPA is lower after oral administration than
after subcutaneous or intraperitoneal delivery
(15). Consistent with those data, Laws and
colleagues (16) demonstrated a greater
increase in uterine wet weight in response to
subcutaneous delivery relative to oral adminis-
tration of equivalent levels of BPA to imma-
ture female rats. With regard to the time of
exposure, oral administration of very low lev-
els of BPA (0.002–0.020 mg/kg) to pregnant
(CF-1) mice during days 11–17 of gestation
produced measurable effects in their offspring
(12,13). Signiﬁcant alterations have also been
reported in the behavior of the offspring of
female Sprague-Dawley rats that were treated
with 0.040–0.40 mg/kg BPA during preg-
nancy and lactation (19). To date, there is no
evidence that these same levels of BPA expo-
sure would exert measurable effects in adults
of the same species and strain.
The particular consequences of estro-
genic exposure and the mechanisms involved
undoubtedly differ depending on the time of
exposure. Limited exposure of adult animals
to estrogenic compounds can produce effects
that are mostly reversible when exposure
ceases. In contrast, perinatal exposure to
exogenous estrogenic compounds is likely to
produce organizational effects that are irre-
versible (20,21). To date, the limited num-
ber of studies that have examined the effects
of perinatal BPA exposure have used differ-
ent species, strains, doses, and routes of
administration, and they have measured dif-
ferent end points (13,14,19,22). Hence,
integrating the available data into a coherent
picture has proven difﬁcult. The aim of the
present study was to assess the effects of BPA
during development and to compare the sen-
sitivity of the developing organism with that
of the adult animal. An oral route of BPA
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The nonsteroidal estrogenic compound bisphenol A (BPA) is a monomer used in the manufacture
of polycarbonate plastics and resins. BPA may be ingested by humans as it reportedly leaches
from the lining of tin cans into foods, from dental sealants into saliva, and from polycarbonate
bottles into their contents. Because BPA is weakly estrogenic—approximately 10,000-fold less
potent than 17β-estradiol—current environmental exposure levels have been considered orders of
magnitude below the dose required for adverse effects on health. Herein we demonstrate measur-
able effects on the offspring of Sprague-Dawley female rats that were exposed, via their drinking
water, to approximately 0.1 mg BPA/kg body weight (bw)/day (low dose) or 1.2 mg BPA/kg
bw/day (high dose) from day 6 of pregnancy through the period of lactation. Offspring exposed
to BPA exhibited an increase in body weight that was apparent soon after birth and continued
into adulthood. In addition, female offspring exposed perinatally to the high dose of BPA exhib-
ited altered patterns of estrous cyclicity and decreased levels of plasma luteinizing hormone (LH)
in adulthood. Administration of neither the doses of BPA that caused effects during perinatal
exposure nor a 10-fold higher dose was able to evoke a uterotropic response in ovariectomized
postpubertal females. These data indicate an increased sensitivity to BPA during the perinatal
period and suggest the need for careful evaluation of the current levels of exposure to this com-
pound. Key words: Bisphenol A, body weight, BPA, development, endocrine disruptors, environ-
mental estrogens, estrous cycles, reproductive function, xenoestrogen. Environ Health Perspect
109:675–680 (2001). [Online 22 June 2001] 
http://ehpnet1.niehs.nih.gov/docs/2001/109p675-680rubin/abstract.htmladministration was chosen for this study to
mimic the most likely route of exposure to
the compound in humans and wildlife.
Materials and Methods
Animals. We purchased female Sprague-
Dawley rats from Taconic Farms
(Germantown, NY). We purchased one
group of 2- to 3-month-old females as
timed pregnant females (n = 18). They were
shipped to our animal facility on day 5 of
pregnancy for the study of BPA exposure
during the perinatal period. We purchased a
second group of animals (n = 30) as ovariec-
tomized young adult females for use in a
uterotropic assay to assess the estrogenicity of
BPA. Animals were maintained in the
Division of Laboratory Animal Medicine with
food (Purina Rodent Chow, St. Louis, MO)
and water available ad libitum. We used glass
water bottles in these studies to ensure that
related compounds did not leach from plastic
water bottles and potentially confound the
results of our studies. We used plastic cages to
house the animals; beforehand, however, we
evaluated ethanol extracts from the cages
using the E-SCREEN assay (23,24) to con-
ﬁrm that measurable levels of estrogenic com-
pounds did not leach from the cages. Animals
were maintained on a light:dark cycle (14:10)
with lights on at 0500 hr and off at 1900 hr.
The care of the animals was in accordance
with the Guidelines for the Care and Use of
Laboratory Animals and the Institutional
Animal Care and Use Committee on our
campus. 
Exposure of pregnant and lactating
females to BPA in the drinking water. Upon
arrival in the facility, the timed pregnant
females were weighed and randomly
assigned to 1 of three groups. We exposed
experimental females to BPA in their drink-
ing water at concentrations of 1 mg/L (low
dose BPA, n = 6) or 10 mg/L (high dose
BPA, n =6) beginning on day 6 of preg-
nancy. BPA exposure was continued
throughout the period of lactation. We gave
control females (n = 6) water containing only
the concentration of ethanol (1%) used as a
diluent for the BPA solutions. Beginning on
the day of weaning, pups were supplied with
unadulterated drinking water.
We estimated the mean levels of BPA
consumed daily by pregnant females from
the drinking water at approximately 0.1
mg/kg bw/day (low dose) and 1.2 mg/kg
bw/day (high dose). These estimates were
based on the measurements of the difference
in the amount of water placed in the water
bottle each day and the amount remaining
on the following day. The assessments
assume that all the water lost from the bottle
was consumed. They do not account for
possible leakage, evaporation, or spillage of
the water or for potential loss of BPA activity
during the 24-hr period. Therefore, the esti-
mates of the level of BPA exposure may be
somewhat higher than actual exposure levels.
The actual levels of BPA that reached the
fetuses during gestation or that were ingested
postnatally by the offspring during the
period of lactation were not estimated in the
present study. 
Assessment of the effects of BPA exposure.
We examined the pregnant females daily and
weighed them several times during preg-
nancy. On the day of delivery, we observed
the females continuously and recorded the
time of delivery of litters for each individual.
The sex of the offspring was initially
recorded on postnatal day 2. We weighed
the pups several times during the neonatal
period and at frequent intervals through 110
days after birth. The body weight data col-
lected before weaning were not segregated by
sex. To facilitate body weight measurements
with the least amount of disruption to the
litters, each pup was removed and rapidly
weighed without ﬁrst assessing its sex. 
Male and female offspring from each of
the three groups were killed at various times
after birth, and the genital tracts were exam-
ined for evidence of macroscopic abnormali-
ties at each time point. We examined the
males neonatally (n = 12), at 3 months (n =
12), and at 5 months (n = 18) and the
females neonatally (n = 12), at 8 months (n
= 24), and at 12–16 months (n = 34). At all
time points, animals were selected from as
many different litters from each group as
possible. For example, we assessed anogenital
distances in animals killed during the neona-
tal period: 12 males and 12 females, includ-
ing one male and one female from four
different litters from each of the three experi-
mental groups. 
We checked female offspring daily begin-
ning on day 28 to assess the day of vaginal
opening. We examined vaginal cytology daily
in the female offspring for 18 consecutive
days at 4 months of age and then again at 6
months of age to determine the pattern of
estrous cyclicity in adulthood (n = 69).
Females were considered to show clear evi-
dence of estrous cyclicity if a minimum of
two, and in many cases three, consecutive
4–5 day estrous cycles were conﬁrmed during
the daily assessments of vaginal cytology.
Eight female offspring in each of the three
groups were ovariectomized and killed 3
months later to assess circulating luteinizing
hormone (LH) levels. We collected trunk
blood and assayed the serum for LH titers
using the rat LH assay kit obtained through
the National Hormone and Pituitary
Program, the National Institute for Diabetes
and Digestive and Kidney Disease (Bethesda,
MD) and A.F. Parlow (LH antisera S-11, lot
number AFP-C697071P). All plasma sam-
ples were run in a single assay. The intra-
assay variability was 7%. 
Uterotropic assay. Two weeks after
ovariectomy, young adult females were
exposed for 3 days to the same two concen-
trations of BPA in their drinking water as
the pregnant and lactating females (1 mg/L
or 10 mg/L)—or a concentration 10 times
greater than the high dose given pregnant
females (100 mg/L). Other groups of identi-
cally treated animals were exposed to estrone
(1 mg/L or 0.1 mg/L) or to water containing
1% ethanol (diluent) for 3 days. We exam-
ined vaginal cytology before treatment began
and then daily during treatment. After 3
days, animals were decapitated and the uter-
ine wet weights were determined. We exam-
ined the animals carefully to conﬁrm that no
ovarian tissue remnants were present. 
Statistical analysis. Overall differences in
body weights, LH levels and uterine wet
weight were analyzed by ANOVA. Once sig-
nificance was established, post hoc tests
(t-tests, Tukey, or LSD) were performed to
make comparisons between groups. The inci-
dence of mammary tumors was analyzed by
the chi-square test. Overall comparisons of
the proportion of cycling females at 4 and 6
months were made using the Kruskall-Wallis
test, and Mann-Whitney U tests were used to
compare between groups where appropriate. 
Results
The ﬁrst signiﬁcant ﬁndings we noted were
increased body weights of the pups born to
BPA-treated females relative to those born to
control females. On postnatal days 4, 7, and
11 (Figure 1), animals exposed to both low-
and high-dose BPA treatments weighed
more than animals born to control females
(p < 0.0001). On days 11 (p < 0.025, Figure
1) and 22 (p <  0.005, Figure 2A and C),
animals exposed to the low dose of BPA
were heavier than those exposed to the high
dose of BPA. On day 28, we observed a sig-
nificant difference in mean body weight
between high- and low-dose animals in the
females (p < 0.005; Figure 2A) but not in
their male littermates (Figure 2C), although
the male offspring did exhibit significant
body weight effects of BPA through postna-
tal day 54 (Figure 2D). On days 87 and 110,
low-dose BPA females retained higher body
weights than both control and high-dose
females (p < 0. 05; Figure 2B). 
We observed evidence of functional
alterations of the reproductive system in
female offspring exposed to the high-dose
regimen of BPA. Most females exposed peri-
natally to high-dose BPA failed to exhibit
evidence of regular estrous cycles when
examined at 4 months (only 21% exhibited
regular estrous cycles) and at 6 months [only
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3A)]. The defect in the pattern of estrous
cyclicity varied in individual females and was
not easily defined. The vaginal cytology of
some animals revealed intermittent extended
periods of diestrus, whereas others exhibited
extended periods of proestrus and/or estrus.
The difference between the animals exposed
to high-dose BPA and those exposed to vehi-
cle was statistically signiﬁcant (p < 0.0001 at
4 months, p < 0.005 at 6 months). A lower
percentage of the animals exposed to the
low-dose regimen of BPA exhibited regular
estrous cycles at 4 months (67%) relative to
the control females (83%); however, this dif-
ference was not signiﬁcant. The mean num-
ber of regular 4–5 day estrous cycles
conﬁrmed for offspring of the high-dose ani-
mals differed significantly from the mean
number confirmed in offspring of control
and low-dose females (Figure 3B). 
Besides altered patterns of estrous cyclic-
ity, the offspring of the high-dose BPA
females also revealed signiﬁcantly lower levels
of plasma LH relative to control females after
long-term ovariectomy (Table 1). Although
plasma LH levels were lower in the low-dose
BPA animals relative to the controls, this dif-
ference was not signiﬁcant probably because
of the variability observed in this group. 
During observations of the female off-
spring, which extended through 16 months of
age when the last group of animals was sacri-
ﬁced, 10% of the female offspring of controls
(2/19), 20% of female offspring exposed to
the low dose (3/15), and 28% exposed to the
high dose (7/25) of BPA developed mammary
tumors. Although the data are provocative,
the differences in the incidence of mammary
tumors were not statistically signiﬁcant. The
precise time that each tumor was ﬁrst palpable
is not known because regular examination for
mammary tumor development had not been
planned. Rather, the tumors were detected
during routine handling of the animals when
they had reached a diameter > 1 cm. 
Many parameters examined in this study
were not significantly affected by perinatal
exposure to BPA. The mean number of pups
per litter did not differ (control 12.0 ± 0.7;
low dose 11 ± 1.3; high dose 11.6 ± 1.0),
and the sex ratios of the litters were compa-
rable in the three groups. The day of vaginal
opening did not differ among groups ( 34.8 ±
0.22, control; 34.7 ± 0.28 low dose; and 34.8
± 0.30 high dose), nor did measurements of
anogenital distance taken during the neonatal
period. Furthermore, no macroscopic abnor-
malities were observed in genital tract tissues
examined at any time during the study.
Exposure to the same levels of BPA given
to pregnant and lactating mothers was not
able to stimulate a uterotropic response in
ovariectomized postpubertal females (Table
2). Moreover, females that received a dose of
BPA 10 times higher than the high dose
administered to pregnant and lactating
females did not exhibit an increase in uterine
wet weight (Table 2). In contrast, a 4-fold
increase in uterine wet weight occurred in
animals that received levels of the potent
natural estrogen estrone comparable to levels
of BPA received in the low-dose treatment.
Consistent with the increase in uterine wet
weights, all females in this estrone-treated
group exhibited corniﬁed vaginal smears on
the day that they were killed. In contrast, the
vaginal cytology of females in the other
groups examined revealed the predominance
of leukocytes. 
Discussion
Several recent studies have demonstrated
subtle effects rather than gross macroscopic
abnormalities in rodents that were exposed
prenatally and/or neonatally to low doses of
BPA (12,13,19). Our ﬁndings are consistent
with this trend. The increase in body weight
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Figure 1. Mean body weights during postnatal
development. Mean body weights (± SEM) of
male and female offspring on postnatal days 4, 7,
and 11 are depicted. Vehicle, n = 53. Low-dose
BPA, approximately 0.1 mg/kg bw/day; n = 40.
High-dose BPA approximately 1.2 mg/kg bw/day,
n = 51. Although the mean body weight ± SEM
have been graphed for each data point, the SEMs
are not clearly visible because the range of SEMs
for all data points was between 0.9 and 1.4% of
the mean. Offspring of animals exposed to high-
dose or low-dose BPA were heavier than those
born to control females (p < 0.0001). 
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Figure 2. Body weights of male and female offspring from weaning to adulthood (22 through 110 days of
age). Mean body weights (± SEM) of female (A,B) and male (C,D) offspring born to mothers exposed to
BPA (low dose or high dose) or vehicle only (controls) in their drinking water. Vehicle, n = 23 females, 27
males. Low-dose BPA, n = 18 females, 19 males. High-dose BPA, n = 28 females and 19 males. At many of
the time points depicted, both male and female offspring of animals born to control females weighed less
than offspring of BPA-treated females. Female offspring of animals exposed to low-dose BPA were heav-
ier than female offspring of control or high-dose BPA animals. As in Figure 1, some SEMs are not visible in
the graph because of their low values.
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▲observed in the offspring of BPA-treated
female rats in our study conﬁrm and extend
recently published findings in mice. Daily
oral administration of 0.0024 mg BPA/kg to
pregnant mice on days 11–17 of gestation
increased the body weight of female off-
spring (13). Our data demonstrate that BPA
increased body weight in both male and
female rats born to exposed mothers,
although the increase persisted longer in
females. Moreover, in the female offspring,
the lower of the two BPA doses produced a
larger and more persistent effect on body
weight relative to the higher dose. This
intriguing ﬁnding is consistent with the non-
monotonic or inverted-U-shaped dose-
response curve that has been reported with
this compound for prostate wet weight (12). 
In the experiments reported here, the
effects of BPA on body weight were observed
during the period of exposure, and they per-
sisted after BPA administration ceased. The
increase in body weight reported in mice by
Howdeshell et al. (13) was also observed after
in utero exposure to BPA. Both sets of data
suggest that the effect of BPA on body
weight does not require the constant presence
of the stimulus. Similarly, the altered estrous
cycle patterns observed in the female off-
spring of dams exposed during gestation and
lactation to the high dose of BPA occurred
long after BPA exposure ceased. Altered pat-
terns of estrous cyclicity have recently been
reported in adult females examined during
the period of daily exposure to 100 mg
BPA/kg bw administered by oral gavage (16).
However, these apparently comparable
effects on estrous cyclicity are likely to be
mediated through different pathways,
because the latter occurred during exposure
to BPA and the former occurred long after
the exposure had ended. The permanent
alterations in estrous cyclicity we observed in
females exposed to BPA perinatally might be
expected to limit reproductive fertility and
decrease overall reproductive success. 
In a recent study of Sprague-Dawley
female rats, Kwon and colleagues failed to
observe significant differences in body
weight or in patterns of estrous cyclicity
after perinatal exposure to much higher lev-
els of BPA than those used in the present
study (25). Doses up to 320 mg/kg/day
BPA were administered to dams from day
11 of gestation through day 20 of lactation.
Although an oral route of administration
was used in that study, BPA was adminis-
tered daily as a single bolus by oral gavage
and not via continuous low-level exposure in
the drinking water, as in our study. It is not
clear whether the different modes of oral
administration might have influenced the
results observed in the two studies. It is pos-
sible that the physiologic response to a large
bolus of the compound is to activate path-
ways that will ensure its rapid elimination.
Differential processing of high doses relative
to low doses of BPA may contribute to the
inverted-U-shaped nonmonotonic dose-
response curve that has been described for
this and other compounds (12,26). A recent
study demonstrated that oral adiministration
of a bolus of BPA (10 mg/kg or 100 mg/kg)
resulted in the conversion of BPA to the
monoglucuronide conjugate, the major uri-
nary metabolite of the compound (15).
Moreover, after oral gavage, the levels of
BPA detected in plasma were low and the
period of time that detectable levels of BPA
were present in the plasma was abbreviated
relative to subcutaneous or intraperitoneal
routes of administration (15).
Although the observed disruption of reg-
ular estrous cycles indicates that perinatal
exposure to the high dose of BPA altered the
function of the hypothalamic-pituitary-
gonadal axis, the site(s) of the disturbance is
(are) unclear. The decrease in circulating LH
levels also observed in females exposed peri-
natally to the high dose of BPA is consistent
with an effect at the hypothalamic and/or
pituitary level. Mean LH levels in the low-
dose animals did not differ signiﬁcantly from
those in either the control or high-dose
females perhaps because of a higher variabil-
ity. Howdeshell et al. (13) demonstrated that
the sensitivity of mice to BPA can vary
markedly in individual animals. Exposure to
endogenous levels of gonadal steroids in
utero may differ in rodents depending on the
position of the developing embryo and the
sex of proximal littermates in the uterine
horn (27–31). These subtle differences in
exposure to endogenous gonadal steroids
during development may inﬂuence the sensi-
tivity of individual animals to low levels of
exposure to exogenous estrogenic com-
pounds. Evidence for such additive effects
were reported in turtles after in ovo exposure
to exogenous estrogens (32).
The mechanisms by which perinatal
exposure to BPA elicits the effects observed
in our study remain to be determined. It is
interesting to note that the perinatal BPA
exposure here spanned the classically deﬁned
critical period of brain sexual differentiation,
which extends from several days before birth
through approximately postnatal day 10 in
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Table 2. Results of uterotropic assay in ovariectomized young adults. 
Estimated chemical Mean uterine wet
Group No. exposure/day weight (mg ± SEM)
Control 6 78.2 ± 6.1 
Estrone (1 mg/L) 5 0.17 mg/kg bw 326.4 ± 14.9**
Estrone (0.1 mg/L) 5 0.02 mg/kg bw 97.6 ± 5.6
BPA (100 mg/L) 4 16.90 mg/kg bw 82.9 ± 8.9 
BPA ( 10 mg/L) 4  1.90 mg/kg bw 89.9 ± 2.8
BPA (1 mg/L) 4  0.15 mg/kg bw 78.2 ± 5.0
Chemicals were delivered in the drinking water. Controls received vehicle (1% ethanol). 
** Estrone (1mg/L) differs from all other groups, p < 0.0001.
Table 1. Plasma LH levels (mean ± SEM) in
ovariectomized females.
Group No. of rats LH levels (ng/mL)
Control females 7 14.97 ± 0.51
Low-dose females 6 12.17 ± 1.54
High-dose females  8 12.14 ± 0.46*
*p < 0.001, high-dose vs. control females. 
Figure 3. Patterns of estrous cyclicity in female offspring of animals exposed to BPA and vehicle. (A) The
proportion of animals exhibiting evidence of regular 4- or 5-day estrous cycles at 4 and 6 months of age.
Patterns of estrous cyclicity were determined by daily examination of vaginal cytology. (B) The mean
number of regular 4- or 5-day estrous cycles (± SEM) recorded for animals in each group. Vehicle, n = 23.
Low-dose BPA, n = 18. High-dose BPA, n = 28. 
*High-dose vs. control and low-dose females, p < 0.0001; **high-dose vs. control and low-dose females, p < 0.01;
***high-dose vs. control, p < 0.005; high-dose vs. low-dose females, p < 0.025. 
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High-dose BPArats (33). During this time, circulating levels
of testosterone produced by the testes can
affect nervous system development and cause
a male-typical pattern of neuroendocrine
regulation and behavior (33–36). Increased
body weight, premature loss of estrous
cyclicity, and a decrease in postcastration LH
levels have all been documented in females
that were treated with exogenous testos-
terone during development (37,38). Many
of the actions of testosterone during brain
sexual differentiation occur via its local
aromatization to estradiol within specific
sites in the developing brain (33–35), and
the importance of estrogen in the differentia-
tion of male behavioral and neuroendocrine
regulation is supported by many lines of
investigation (reviewed in 35). Therefore, it
is tempting to postulate that the estrogenic
compound BPA, which binds estrogen
receptors (39,40), alters the expression of
estrogen and androgen receptors (41), and
possesses antiandrogenic activities (42), may
have interfered with central processes involved
in brain sexual differentiation in animals
exposed perinatally. As a nonsteroidal estro-
gen, BPA could potentially bypass the pro-
tective mechanisms that limit exposure to
circulating estrogens during fetal and early
neonatal development (34,43,44). In devel-
oping mice and rats, high concentrations of
the liver-secreted protein alpha fetoprotein
bind estradiol and reduce the availability of
this steroid from the circulation during the
critical period of sexual differentiation
(33–35). In contrast, testosterone in the cir-
culation is free to enter the brain, where it
can be converted to estradiol and interact
with estrogen receptors. Behavioral effects
consistent with central actions of BPA dur-
ing development have recently been reported
in rats after oral exposure to BPA at a level
and time frame similar to that used in the
present study (19). 
Perinatal exposure to BPA appeared to
result in a slight but not statistically signiﬁ-
cant increase in the incidence of mammary
tumor development in the female offspring
during the course of our study. These data
are provocative and suggest that a possible
relationship between perinatal exposure to
BPA and mammary tumor development
warrants further investigation. In this regard,
recent epidemiological data suggest that
increased estrogen exposure in utero increases
the risk of breast cancer (45,46). Although
not a result of perinatal exposure, BPA
administration has been reported to stimu-
late lobular maturation and epithelial cell
proliferation in young adult Noble rats (47). 
To date, the relative sensitivity to a spe-
ciﬁc regimen of BPA exposure has not been
assessed in a single animal strain during
development and in adulthood, and the
marked strain differences in BPA sensitivity
(10,11) have hindered the integration of cur-
rently available data. Therefore, we evalu-
ated the sensitivity of ovariectomized adult
Sprague-Dawley rats to BPA, using the
uterotropic assay as a measure of estrogenic-
ity. As shown, exposure to the same levels of
BPA provided to the pregnant and lactating
mothers, as well as a dose 10 times higher
than the high dose, was unable to stimulate
a uterotropic response in ovariectomized
postpubertal females. Moreover, Gould and
colleagues (48) demonstrated that adminis-
tration of even higher doses of BPA (150
mg BPA/kg bw) failed to increase uterine
wet weight in immature Sprague-Dawley
females. The data from the present study
therefore suggest that the sensitivity to BPA
exposure is significantly increased during
early development.
BPA may be particularly deleterious dur-
ing the perinatal period because of its low
binding afﬁnity to serum proteins (49) and
the potential for nonsteroidal estrogenic
compounds to bypass mechanisms that limit
exposure of the fetus and the fetal brain to
circulating estrogens (33,45,46). In addition,
developmental exposure to BPA produces
effects that persist long after the causal agent
is removed. Moreover, the body weight data
in this study suggest that low doses of BPA
may be more effective than high doses in
altering some physiologic parameters. Data
from other studies have demonstrated that
low-dose exposure to this compound may in
fact be more detrimental than high doses
(12) and that persistent exposure to low
doses of the compound over long periods
may be as effective as shorter exposures to
somewhat higher levels (19). These ﬁndings
indicate the compelling need for reevaluation
of the end points used for the toxicologic
assessment of BPA, of the acceptable levels of
exposure to this compound, and of other
xenoestrogens present in the environment.
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